Kaitai Capital
Cathay Capital is a venture capital management institution that invests in businesses.
Business Model: B2B
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Kaitai Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cathay Capital is a venture capital management institution that invests in businesses.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2019 | Exegenesis Bio | Seed Round | 10M |
| 10/2013 | NGames | Angel Round | 491.6k |
| 5/2018 | Dadaozhichuang | Series A | - |
| 1/2018 | U Voice | Series A | 1.6M |
| 12/2021 | Redesign Science | Seed Round | 0 |
| 6/2022 | Yiwise | Series B | 14.9M |
| 6/2022 | Yiwise | Series B | - |
| 2/2019 | Doer Biologics | Series A | - |
| 4/2010 | 9LINK | Angel Round | 439.4k |
| 1/2019 | Wangbaobao | Angel Round | 1.5M |
| 1/2022 | Ceram Pharmaceuticals | Series A | 31.5M |
| 12/2016 | Crabyter | Series B | 2.9M |
| 8/2016 | Momfo | Series A | 14.3M |
| 8/2017 | Dengta | Series A | 8.3M |
| 2/2019 | LYNK Pharmaceuticals | Seed Round | - |
| 3/2019 | Gaochun Pharmaceutical | Corporate Round | - |
| 3/2019 | Forkhead BioTherapeutics | Seed Round | - |
| 1/2018 | Chance Pharmaceuticals | Series A | 8.4M |
| 9/2021 | Ai Industry | Series A | - |
| 3/2020 | F&a;S Pharmatech | Series B | - |
| 4/2022 | Worktile | Series C | 15.2M |
| 7/2022 | Lituo Biotechnology | Seed Round | - |
| 8/2014 | TClab | Angel Round | 488k |
| 9/2018 | Imperial Vision Technology | Series A | 2.9M |
| 12/2021 | CirCode | Seed Round | 20M |
| 9/2018 | F&a;S Pharmatech | Series A | 7.3M |
| 9/2020 | Totient | Seed Round | 0 |
| 12/2021 | Circular Code Biology | Seed Round | 20M |
| 10/2021 | Axbio | Series B | 10M |
| 1/2018 | Ling Miao Keji | Series A | 1.5M |
| 12/2021 | BioBin Data Science | Seed Round | 1.6M |
| 7/2022 | Wangfanxin | Series A | 0 |
| 6/2017 | Atom Bioscience &a; Pharmaceutical | Series A | - |
| 4/2020 | LYNK Pharmaceuticals | Series A | - |
| 4/2022 | Ke Ning Bio | Seed Round | 0 |
| 9/2022 | Realibox | Series A | 14M |
| 5/2015 | QY NODE | Angel Round | 808.3k |
| 9/2016 | SEECOME | Angel Round | 0 |
| 9/2011 | ZOCAI | Venture Round | 31.3M |
| 12/2015 | U Voice | Angel Round | 0 |
| 7/2016 | Quku Technology | Angel Round | 450.4k |
| 4/2015 | Zdjoys.com | Venture Round | 8.1M |
| 4/2022 | Pleryon Therapeutics | Seed Round | 0 |
| 7/2017 | Niuniuqiche | Series A | 17M |
| 3/2018 | LYNK Pharmaceuticals | Angel Round | 10M |
| 3/2020 | Asieris Pharmaceuticals | Series C | 14.2M |
| 11/2017 | Sanbo Brain Hospital | Series A | - |
| 5/2018 | Licai Mofang | Series A | 6.3M |
| 10/2018 | JeniVision | Corporate Round | - |
| 12/2021 | West Lake Xinchen | Angel Round | - |
| 11/2018 | Abcuro | Series A | 0 |
| 4/2020 | Rgenta Therapeutics | Seed Round | 20M |
| 1/2016 | CARsgen Therapeutics | Series B | 30M |
| 12/2020 | ONL Therapeutics | Series B | 0 |
| 12/2017 | Asieris Pharmaceuticals | Series B | 15.4M |
| 5/2021 | BridGene Biosciences | Series A | 0 |
| 7/2021 | Hongyun Biotech | Series B | 15.4M |
| 6/2022 | YizhiIntelligent | Series B | 0 |
| 11/2021 | Mingsight Pharmaceuticals | Series B | 20M |
| 8/2018 | Tekeluo Biotech | Series A | 4.7M |
| 1/2017 | Tree Fintech | Series A | 5.8M |
| 9/2022 | Worg Pharmaceuticals | Series B | 57.5M |
| 2/2022 | TaoCloud | Series C | 865.5k |
| 1/2022 | Atom Bioscience &a; Pharmaceutical | Series C | 45M |
| 5/2020 | Atom Bioscience &a; Pharmaceutical | Series B | 30M |
| 12/2014 | BeiJing BoYiChuangWei Digital Media Co.,Ltd | Series A | 1.6M |
| 1/2016 | Winturn Games | Angel Round | 456.7k |
| 1/2022 | Bivision | Seed Round | - |
| 1/2022 | Junsai Shengwu | Series A | 0 |
| 1/2016 | Wanli Niu | Series A | 3M |
| 5/2021 | Rgenta Therapeutics | Seed Round | 18M |
| 9/2019 | Amphivena Therapeutics | Series C | 0 |
| 12/2021 | Zhiyan Technology | Series B | 15.7M |
| 2/2021 | Teon Therapeutics | Series A | 0 |
| 7/2022 | Apache DolphinScheduler | Angel Round | 0 |
| 2/2021 | Exegenesis Bio | Series B | - |
| 12/2015 | yundai365.com | Angel Round | 1.6M |
| 10/2017 | New Tranx Information Technology | Seed Round | 0 |
| 2/2022 | GluBio Therapeutics | Series A | 0 |
| 1/2021 | Worg Pharmaceuticals | Series A | 30.8M |
| 4/2021 | PackGene Biotech | Series C | - |
| 9/2020 | OncoImmune | Series B | 56M |
| 11/2022 | Rgenta Therapeutics | Series A | 0 |
| 6/2018 | Astrocyte Pharmaceuticals | Seed Round | 0 |
| 8/2022 | Bivision | Angel Round | 14.9M |
| 9/2015 | Yunweikang | Series A | 3.1M |
| 8/2018 | Weijian Pharmaceutical Group Co. | Corporate Round | 10M |
| 8/2018 | ForDearMe | Series A | 1.5M |
| 6/2018 | Carephar | Corporate Round | - |
| 7/2022 | Wangfanxin | Series A | 0 |
| 7/2022 | Apache DolphinScheduler | Angel Round | 0 |
| 6/2022 | YizhiIntelligent | Series B | 0 |
| 6/2022 | Yiwise | Series B | - |
| 4/2022 | Worktile | Series C | 0 |
| 4/2022 | Ke Ning Bio | Seed Round | 0 |
| 4/2022 | Pleryon Therapeutics | Seed Round | 0 |
| 2/2022 | GluBio Therapeutics | Series A | 0 |
| 2/2022 | TaoCloud | Series C | 0 |
| 1/2022 | Junsai Shengwu | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
